Schedule 13D ownership disclosure

TRINITY BIOTECH INVT LTD

Class A Ordinary Shares, $0.0109 par value per share · CUSIP: 896438504

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Perceptive Advisors LLCReported CIK 0001224962

    Shares: 85,800,000 · Class: 20.9%

  • Perceptive Credit Advisors LLCReported CIK 0001877081

    Shares: 85,800,000 · Class: 20.9%

  • Joseph EdelmanReported CIK 0001164426

    Shares: 85,800,000 · Class: 20.9%

  • Perceptive Credit Holdings II, L.P.

    Shares: 45,800,000 · Class: 11.4%

  • Perceptive Credit Holdings III, L.P.Reported CIK 0001877078

    Shares: 40,000,000 · Class: 9.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-021237
Form type
SCHEDULE 13D/A
Filer
PERCEPTIVE ADVISORS LLC
CIK
CIK 1224962
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub